Michael Kelly, MD, MPH, MS is a seasoned clinical development expert currently serving as Vice President of Clinical Development at Hemab Therapeutics since March 2025. Previously, Michael held various leadership roles at Syros Pharmaceuticals from March 2019 to December 2024, including Vice President and Head of Clinical Development, Executive Director of Clinical Research, Senior Medical Director, and Medical Director. Prior experience includes serving as Division Chief of Pediatric Hematology Oncology and attending physician at Tufts Medical Center from July 2009 to February 2019, as well as positions at Hasbro Children’s Hospital from July 2002 to July 2009, where Michael completed a fellowship and served as Pediatric Chief Resident. Academic credentials include a Master of Public Health from Brown University, a Doctor of Medicine from Drexel University College of Medicine, and a Master of Science in Clinical & Translational Science from Tufts University.
This person is not in any teams
This person is not in any offices